AI in drug discovery

News

Takeda signs $1.7bn AI alliance with Iambic

Iambic bags another pharma partner, Takeda, which plans to use its AI platform to find drugs for cancer, gastrointestinal, and inflammatory disorders.

Digital

Activation of the G protein-coupled GABA B receptor by the agonist baclofen

How GenAI is cracking the toughest targets in drug discovery

Generative AI has the potential to solve for designing effective antibodies for G‑protein coupled receptors (GPCRs).

R&D

Changing how the world finds new medicines: Physics modellin...

Finding treatments for diseases afflicting humanity often proceeds at a crawl, leaving many serious medical needs unmet.

Digital

pharmaphorum podcast Episode 242, Yann Gaston-Mathe, Iktos

JPM2026: Broadening AI drug discovery to include the lab, wi...

Yann Gaston-Mathe, founder and CEO of Iktos, discusses AI drug discovery's shift to real-world operations that are able to incorporate wet lab data.

News

Sarah Skerrat, Isomorphic's chief research officer

J&J bets on Isomorphic for AI-powered drug hunt

Isomorphic Labs has added Johnson & Johnson to the roster of pharma companies tapping into its AI-based drug discovery engine.

News

EMA and FDA agree 'principles' for AI in drug development

The FDA and EMA have come up with guiding principles that they say will underpin future guidance on the use of AI technologies in drug development.

Takeda signs $1.7bn AI alliance with Iambic

How GenAI is cracking the toughest targets in drug discovery

Changing how the world finds new medicines: Physics modellin...

JPM2026: Broadening AI drug discovery to include the lab, wi...

J&J bets on Isomorphic for AI-powered drug hunt

EMA and FDA agree 'principles' for AI in drug development

Madrigal builds in MASH with $4.4bn+ Ribo alliance

How to meet your physicians where they are online

AI in drug discovery

Editor's Picks